Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Early markers of metabolic syndrome in nonoverweight, middle-aged men

Nature Clinical Practice Urology volume 3, pages 524–525 (2006)Cite this article

boxed-textKupelian V et al. (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91: 843–850

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Grundy SM et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735–2752

    Article  Google Scholar 

  2. Kahn R et al. (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289–2304

    Article  Google Scholar 

  3. Laaksonen DE et al. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27: 1036–1041

    Article  CAS  Google Scholar 

  4. Bhasin S et al. (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91: 1995–2010

    Article  CAS  Google Scholar 

  5. Liu PY et al. (2004) Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 89: 4789–4796

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Carol Lovegrove, Freelance Medical Writer.

Author information

Author notes

  1. PY Liu is a National Health and Medical Research Council (Australia) Neil Hamilton Fairley Postdoctoral Fellow (Grant ID 262025)

Authors and Affiliations

  1. the Director of theANZAC Research Institute, University of Sydney and Concord Hospital, Sydney, Australia

    Peter Y Liu & David J Handelsman

Authors
  1. Peter Y Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David J Handelsman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Y Liu.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, P., Handelsman, D. Early markers of metabolic syndrome in nonoverweight, middle-aged men. Nat Rev Urol 3, 524–525 (2006). https://doi.org/10.1038/ncpuro0599

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0599

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing